tradingkey.logo
tradingkey.logo
Search

Beam Therapeutics Inc

BEAM
Add to Watchlist
26.410USD
+0.540+2.09%
Close 11-06 16:00(ET)
2.73BMarket Cap
LossP/E TTM

BEAM Financials

See Beam Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
2.73B
Dividend TTM
0.00
P/E TTM
-53.84
EPS TTM
-0.49
Revenue
139.74M
Net Profit
-376.74M
ROE
-5.77%
ROA
-4.48%
Beam Therapeutics Inc Earnings Date
Latest Release
Nov 3, 2026
EPS / Forecast
-1.28/-1.16
Revenue / Forecast
307.00K/8.75M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-16.81%-1.28
-17.25%-1.18
26.46%-0.91
317.59%2.37
6.31%-1.10
9.33%-1.00
-2.84%-1.24
-161.80%-1.09
3.53%-1.17
-2.01%-1.11
9.51%-1.21
425.81%1.77
---1.22
---1.08
---1.33
---0.54
---3.59
----
----
----
Revenue
-96.83%307.00K
-94.21%490.00K
324.87%31.74M
279.52%114.11M
-32.03%9.70M
-28.08%8.47M
0.81%7.47M
-90.49%30.07M
-17.01%14.27M
-41.48%11.77M
-69.39%7.41M
1478.04%316.19M
8.82%17.19M
20.80%20.12M
187.10%24.21M
-60.76%20.04M
1970.64%15.80M
277433.33%16.65M
140433.33%8.43M
851050.00%51.07M
Net Profit
-19.23%-134.41M
-20.11%-122.68M
13.68%-94.32M
370.38%244.30M
-16.61%-112.73M
-12.34%-102.29M
-10.74%-109.27M
-163.27%-90.35M
-0.60%-96.67M
-10.00%-91.05M
-2.29%-98.67M
472.36%142.80M
12.31%-96.09M
-15.05%-82.78M
-39.36%-96.46M
40.73%-38.35M
-289.70%-109.58M
5.64%-71.95M
65.66%-69.21M
32.22%-64.71M
Net Margin
-3666.41%-43780.13%
-1972.10%-25036.33%
79.68%-297.18%
171.24%214.09%
-71.58%-1162.38%
-56.22%-1208.26%
-9.85%-1462.78%
-765.41%-300.51%
-21.22%-677.47%
-87.96%-773.45%
-234.18%-1331.57%
123.60%45.16%
---558.88%
---411.49%
---398.46%
---191.39%
---613.31%
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
Debt to assets ratio
--7.91%
--7.23%
--6.77%
----
----
----
----
----
----
----
----
-85.20%0.03%
--0.11%
--0.13%
--0.18%
--0.22%
--0.27%
----
----
----
Revenue
-96.83%307.00K
-94.21%490.00K
324.87%31.74M
279.52%114.11M
-32.03%9.70M
-28.08%8.47M
0.81%7.47M
-90.49%30.07M
-17.01%14.27M
-41.48%11.77M
-69.39%7.41M
1478.04%316.19M
8.82%17.19M
20.80%20.12M
187.10%24.21M
-60.76%20.04M
1970.64%15.80M
277433.33%16.65M
140433.33%8.43M
851050.00%51.07M
Operating profit
-11.44%-141.32M
-5.33%-126.55M
10.12%-107.22M
82.56%-17.45M
-19.07%-126.81M
-14.54%-120.15M
-14.55%-119.29M
-175.30%-100.04M
1.63%-106.50M
-2.69%-104.89M
-5.26%-104.13M
249.30%132.86M
-18.58%-108.27M
-24.62%-102.15M
-29.78%-98.93M
-40.17%-88.98M
-31.12%-91.30M
-38.99%-81.97M
61.96%-76.22M
-55.60%-63.48M
Net Profit
-19.23%-134.41M
-20.11%-122.68M
13.68%-94.32M
370.38%244.30M
-16.61%-112.73M
-12.34%-102.29M
-10.74%-109.27M
-163.27%-90.35M
-0.60%-96.67M
-10.00%-91.05M
-2.29%-98.67M
472.36%142.80M
12.31%-96.09M
-15.05%-82.78M
-39.36%-96.46M
40.73%-38.35M
-289.70%-109.58M
5.64%-71.95M
65.66%-69.21M
32.22%-64.71M
Current assets
-2.84%1.07B
0.27%1.18B
1.55%1.27B
44.47%1.27B
16.18%1.10B
14.18%1.18B
11.22%1.25B
-27.49%878.15M
-9.04%945.53M
-5.97%1.03B
3.57%1.12B
10.81%1.21B
-6.26%1.04B
-7.21%1.09B
-12.62%1.08B
-14.15%1.09B
17.79%1.11B
74.03%1.18B
140.87%1.24B
312.88%1.27B
Total current liabilities
-55.04%82.08M
-53.55%80.88M
-47.32%74.56M
-46.76%96.94M
9.81%182.56M
-1.81%174.13M
-24.40%141.55M
-11.43%182.07M
-24.56%166.24M
-15.37%177.33M
-14.87%187.22M
-8.06%205.56M
-7.74%220.37M
-1.29%209.54M
0.52%219.93M
4.76%223.59M
135.58%238.86M
64.92%212.28M
114.33%218.80M
108.56%213.44M
Total assets
-3.20%1.27B
-0.35%1.39B
0.95%1.48B
34.19%1.48B
11.93%1.31B
10.30%1.39B
7.88%1.47B
-24.38%1.10B
-9.23%1.17B
-6.84%1.26B
2.06%1.36B
8.79%1.46B
-4.42%1.29B
-4.55%1.35B
-8.33%1.33B
-9.00%1.34B
16.75%1.35B
58.82%1.42B
109.65%1.45B
226.44%1.47B
Total liabilities
-8.31%316.40M
-7.39%318.91M
-7.98%316.36M
-34.42%242.82M
-9.20%345.08M
-15.43%344.34M
-22.97%343.78M
-22.60%370.28M
-25.71%380.05M
-24.91%407.17M
-21.82%446.31M
-21.35%478.38M
-19.53%511.59M
-12.29%542.24M
-8.57%570.85M
-6.09%608.24M
110.01%635.77M
79.44%618.21M
130.54%624.33M
214.25%647.72M
Total equity
-1.38%952.67M
1.97%1.07B
3.68%1.16B
68.82%1.24B
22.08%966.00M
22.56%1.05B
22.95%1.12B
-25.25%733.54M
1.59%791.32M
5.23%854.09M
19.96%913.49M
33.79%981.33M
9.02%778.94M
1.43%811.64M
-8.15%761.51M
-11.28%733.47M
-16.32%714.48M
45.87%800.16M
96.26%829.07M
236.67%826.74M
Net operating income
-35.92%-110.75M
13.54%-66.10M
-23.71%-128.51M
-9.07%-83.29M
7.54%-81.48M
7.90%-76.45M
-4.15%-103.88M
-156.54%-76.36M
1.85%-88.13M
1.96%-83.01M
9.17%-99.75M
295.22%135.07M
-20.52%-89.78M
-61.97%-84.67M
-150.26%-109.81M
-3880.93%-69.19M
-2577.42%-74.50M
-60.72%-52.28M
666.36%218.49M
107.53%1.83M
Net investment
55.14%101.86M
94.21%-9.88M
120.20%25.27M
-14.15%108.41M
165.83%65.66M
-294.77%-170.41M
-133.97%-125.09M
28.73%126.28M
341.43%24.70M
310.93%87.49M
-310.07%-53.46M
-13.52%98.10M
71.72%-10.23M
-3186.85%-41.48M
104.74%25.45M
246.38%113.44M
-147.53%-36.17M
90.39%-1.26M
-92.16%-537.34M
4.83%-77.50M
Net financing
38.93%2.33M
578.36%7.52M
-79.59%96.61M
-45.24%1.89M
32.73%1.68M
733.83%1.11M
16240.32%473.38M
-89.78%3.44M
-96.57%1.26M
-99.88%133.00K
-97.06%2.90M
5.31%33.71M
2254.48%36.78M
381.39%107.54M
76.77%98.42M
48.60%32.01M
-99.51%1.56M
-86.08%22.34M
-78.02%55.68M
-83.43%21.54M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its total revenue reached 139.74M, with a year-on-year change of 63.52M.

What are the current assets of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its current assets were 1.27B, with a year-on-year change of 44.47.

What are the total assets of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its total assets of Beam Therapeutics Inc were 1.48B, with a year-on-year change of 34.19.

What are the total liabilities of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its total liabilities of Beam Therapeutics Inc were 242.82M, with a year-on-year change of -34.42.

What is the total equity of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its total equity of Beam Therapeutics Inc was 1.24B, with a year-on-year change of 68.82.

What is the net operating income of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its net operating income of Beam Therapeutics Inc was -383.69M, with a year-on-year change of 7.67.

What is the net investment of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its net investment of Beam Therapeutics Inc was -121.44M, with a year-on-year change of -165.64.

What is the net financing of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its net financing of Beam Therapeutics Inc was 478.05M, with a year-on-year change of 6079.54.

What is the Earnings Per Share (EPS) of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.81, with a year-on-year change of 82.33.

What is the net income of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its net income was -79.99M, with a year-on-year change of 78.77.

What is the net margin of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its net profit margin was -57.24, with a year-on-year change of 90.35.

What is the Return on Equity (ROE) of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -8.11, with a year-on-year change of 81.54.

What is the Return on Assets (ROA) of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -6.19, with a year-on-year change of 78.94.

What is the operating profit of Beam Therapeutics Inc?

According to Beam Therapeutics Inc's FY2025 earnings report, its operating profit was -383.69M, with a year-on-year change of 7.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.